- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by novoGI
Total 1677 results
-
Novo Nordisk A/SCompletedHealthy Volunteers | Atherosclerotic Cardiovascular DiseaseJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United Kingdom
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, South Africa, Russian Federation, Former Serbia and Montenegro, North Macedonia
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsUnited States
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SEnrolling by invitation
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Slovakia, Czechia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SWithdrawnDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Chronic Kidney Disease
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesUnited Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTaiwan
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | Diabetes
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesFrance
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSpain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Serbia, South Africa, Taiwan, Romania, Algeria, Hong Kong, Brazil, China, Czechia
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedOverweight and ObesityJapan, Korea, Republic of
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited Kingdom, France
-
Novo Nordisk A/STerminated
-
Novo Nordisk A/SCompletedNoonan Syndrome | Genetic DisorderSweden
-
Novo Nordisk A/SEnrolling by invitation
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderFrance, United States, Turkey, Italy, Australia, New Zealand, Canada, Netherlands
-
Novo Nordisk A/SEnrolling by invitationObesity | OverweightUnited States, Saudi Arabia, Brazil, Canada, Spain
-
Novo Nordisk A/SCompletedChronic Kidney Disease (CKD) | Atherosclerotic Cardiovascular Disease (ASCVD)India
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2China
-
Novo Nordisk A/SCompletedHealthy Volunteers Type 2 DiabetesJapan
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Puerto Rico, Canada, Hungary, Greece, Japan, Bulgaria, Slovakia, Ukraine, Czechia
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderItaly, Germany
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1Austria
-
Novo Nordisk A/SCompletedObesity | OverweightDenmark
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Lebanon
-
Novo Nordisk A/SCompletedNoonan Syndrome | Genetic DisorderJapan
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedType 2 Diabetes | Healthy VolunteersGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Israel, Italy, Mexico, United Kingdom, Canada, Denmark, Spain, Netherlands, Malaysia, Taiwan, Germany, Poland, Turkey, Argentina, South Africa, Romania, Thailand, Algeria, Brazil
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Austria, Belgium, Norway, Turkey, Switzerland, Argentina, Korea, Republic of, Brazil, Egypt
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Croatia, Japan, Slovakia, Germany, Latvia, South Africa, Czechia, United Arab Emirates, Hungary, Ukraine, Puerto Rico